The product info for GLP-1s within the UK will now embrace warnings over their potential hyperlinks to acute pancreatitis, regulators have introduced.
GLP-1s have been linked to quite a lot of unwanted side effects, together with gastrointestinal signs, blindness, and hair loss.
Some of the severe unwanted side effects that has been related to GLP-1s is acute pancreatitis (swollen pancreas). Based on the UK’s Medicines and Healthcare merchandise Regulatory Company (MHRA), 1,296 instances of acute pancreatitis have been related to the medicine between 2007 and October 2025. Of those, 19 have been reported as deadly.
Now, UK regulators have introduced that product info for GLP-1s, in addition to twin GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, will embrace warnings over the illness.
A warning has additionally been issued to medical doctors to search for potential signs of pancreatitis in sufferers handled with GLP-1s, reminiscent of extreme stomach ache accompanied by nausea and vomiting. In the event that they develop these signs, sufferers are suggested to hunt pressing medical consideration.
What this implies for meals
Regardless of the immense recognition of GLP-1s, there are some indicators {that a} slowdown may very well be imminent.
One of many chief causes that buyers are sceptical of the medicine is the multitude of potential side-effects, reminiscent of gastrointestinal troubles and puffy ‘Ozempic face’, the sagging pores and skin and wrinkles typically related to GLP-1s.
As the chance of acute pancreatitis is taken extra critically by authorities, may this improve client scepticism in direction of the medicine? In that case, may this in flip reduce the disruption they could have on the meals business?
Business’s response
In response, a spokesperson for Wegovy and Ozempic maker Novo Nordisk stated: “Affected person security is of the utmost significance to Novo Nordisk. Like all drugs, unwanted side effects can happen and range from affected person to affected person. The recognized dangers and advantages of GLP-1 medicines are described within the Abstract of Product Traits.
“We suggest that sufferers take these drugs just for their accredited indications and underneath the strict supervision of a healthcare skilled, who also can advise on potential unwanted side effects. Though the frequency of acute pancreatitis is unusual, healthcare professionals needs to be conscious that pancreatitis has been related to GLP-1 and GLP-1/GIP receptor agonists, and to remain alert to indicators and signs of their sufferers.”
The spokesperson stresses that Novo Nordisk continues to gather security information, and that it welcomes any new analysis that can assist it perceive GLP-1 therapies.
Mounjaro and Zepbound maker Eli Lilly additionally burdened that its product info warns acute pancreatitis could also be a facet impact, and that sufferers ought to seek the advice of a physician or healthcare skilled earlier than utilizing these merchandise if they’ve ever had the sickness.
Need to know extra concerning the impression of GLP-1s on F&B?
Be part of us at Optimistic Vitamin, a collection of broadcast occasions spotlighting the improvements and applied sciences central to the evolution of better-for-you food and drinks.
On 5 February 2026, we’ll be internet hosting a session titled: World GLP-1 disruption.
Weight-loss jabs are taking the world by storm, reshaping the whole lot from client habits to product innovation. Their impression is being felt throughout areas and throughout classes, however the impact in a single sector isn’t at all times mirrored in one other. From gentle drinks to alcohol, confectionery to snacks, we dissect the disruption and ask what’s subsequent.
